Harvard Bioscience, Inc. ( HBIO) - Key Metrics
HBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $5.35 | -$0.64 | -$0.02 | -$0.12 |
| 2025Q3 | $4.62 | -$0.28 | $0.19 | $0.14 |
| 2025Q2 | $4.62 | -$0.52 | $0.62 | $0.57 |
| 2025Q1 | $4.94 | -$11.42 | $0.68 | $0.56 |
HBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.61 |
| 2025Q3 | ? | -3.97 |
| 2025Q2 | ? | -2.15 |
| 2025Q1 | ? | -0.12 |
HBIO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -4.99% | ? |
| 2025Q4 | -1.84% | ? |
| 2025Q3 | 3.19% | ? |
| 2025Q2 | 12.82% | ? |
| 2025Q1 | 9.91% | ? |
HBIO
Price: $6.20
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.15 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 13674
Ebitda: 836000Market Capitalization: 29.3 million